Yener S. Erozan
Ibrahim Ramzy

2014

Recent developments in molecular markers are changing the landscape of our understanding of lung disease, particularly lung cancer, and opening the field for targeted therapies. The role of cytopathology in planning and delivery of personalized medicine is poised for a significant and exciting leap.